APA (7th ed.) Citation

Bissonnette, R., Vasist, L. S., Bullman, J. N., Collingwood, T., Chen, G., & Maeda‐Chubachi, T. (2018). Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study. Clinical Pharmacology in Drug Development, 7(5), 524. https://doi.org/10.1002/cpdd.439

Chicago Style (17th ed.) Citation

Bissonnette, Robert, Lakshmi S. Vasist, Jonathan N. Bullman, Therese Collingwood, Geng Chen, and Tomoko Maeda‐Chubachi. "Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study." Clinical Pharmacology in Drug Development 7, no. 5 (2018): 524. https://doi.org/10.1002/cpdd.439.

MLA (9th ed.) Citation

Bissonnette, Robert, et al. "Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study." Clinical Pharmacology in Drug Development, vol. 7, no. 5, 2018, p. 524, https://doi.org/10.1002/cpdd.439.